Shandong Pharmaceutical Valuation
| 600529 Stock | 25.01 0.25 0.99% |
At this time, the company appears to be overvalued. Shandong Pharmaceutical has a current Real Value of USD21.43 per share. The regular price of the company is USD25.01. Our model measures the value of Shandong Pharmaceutical from inspecting the company fundamentals such as Shares Outstanding of 663.61 M, operating margin of 0.25 %, and Return On Equity of 0.12 as well as reviewing its technical indicators and probability of bankruptcy.
Price Book 2.1525 | Enterprise Value 13.9 B | Enterprise Value Ebitda 13.2148 | Price Sales 3.2254 | Trailing PE 18.7594 |
Overvalued
Today
Please note that Shandong Pharmaceutical's price fluctuation is very steady at this time. Calculation of the real value of Shandong Pharmaceutical is based on 3 months time horizon. Increasing Shandong Pharmaceutical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Shandong Pharmaceutical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Shandong Stock. However, Shandong Pharmaceutical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 25.01 | Real 21.43 | Hype 25.13 | Naive 24.55 |
The real value of Shandong Stock, also known as its intrinsic value, is the underlying worth of Shandong Pharmaceutical Company, which is reflected in its stock price. It is based on Shandong Pharmaceutical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Shandong Pharmaceutical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Shandong Pharmaceutical Glass helps investors to forecast how Shandong stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Shandong Pharmaceutical more accurately as focusing exclusively on Shandong Pharmaceutical's fundamentals will not take into account other important factors: Shandong Pharmaceutical Cash |
|
Shandong Pharmaceutical Total Value Analysis
Shandong Pharmaceutical Glass is presently forecasted to have takeover price of 13.9 B with market capitalization of 16.56 B, debt of 1.83 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Shandong Pharmaceutical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
13.9 B | 16.56 B | 1.83 M |
Shandong Pharmaceutical Investor Information
About 20.0% of the company shares are owned by insiders or employees . The book value of Shandong Pharmaceutical was presently reported as 11.74. The company last dividend was issued on the 11th of October 2024. Shandong Pharmaceutical had 1.4:1 split on the 20th of June 2019. Shandong Pharmaceutical Glass is performing exceptionally good at this time. It has a great probability to report excellent financial results in February.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 1.3 B | 1.2 B |
|
| |||||
| Operating Income | 1.1 B | 1 B |
|
|
Shandong Pharmaceutical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Shandong Pharmaceutical has an asset utilization ratio of 53.46 percent. This suggests that the Company is making USD0.53 for each dollar of assets. An increasing asset utilization means that Shandong Pharmaceutical Glass is more efficient with each dollar of assets it utilizes for everyday operations.Shandong Pharmaceutical Ownership Allocation
Shandong Pharmaceutical shows a total of 663.61 Million outstanding shares. Shandong Pharmaceutical has significant amount of outstanding shares owned by insiders and institutional investors .Since such a large part of the company is not owned by regular investors, we recommend to check if there were significant buying or selling the Shandong Pharmaceutical stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Shandong Pharmaceutical Profitability Analysis
The company reported the revenue of 4.98 B. Net Income was 775.8 M with profit before overhead, payroll, taxes, and interest of 1.12 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Shandong Pharmaceutical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Shandong Pharmaceutical and how it compares across the competition.
About Shandong Pharmaceutical Valuation
The stock valuation mechanism determines Shandong Pharmaceutical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Shandong Pharmaceutical. We calculate exposure to Shandong Pharmaceutical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Shandong Pharmaceutical's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 1.6 B | 1.1 B |
Shandong Pharmaceutical Quarterly Retained Earnings |
|
Complementary Tools for Shandong Stock analysis
When running Shandong Pharmaceutical's price analysis, check to measure Shandong Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shandong Pharmaceutical is operating at the current time. Most of Shandong Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Shandong Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shandong Pharmaceutical's price. Additionally, you may evaluate how the addition of Shandong Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Stocks Directory Find actively traded stocks across global markets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |